Bill Gates giving $50 million for Alzheimer's research

November 13, 2017

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.

Gates, in an entry on his blog, said he was making the investment from his personal fortune and not with his charitable Bill & Melinda Gates Foundation.

"Of all the disorders that plague us late in life, one stands out as a particularly big threat to society: Alzheimer's disease," Gates said.

"Scientists have yet to figure out what exactly causes Alzheimer's or how to stop the disease from destroying the brain," he said. "In the United States, it is the only cause of death in the top 10 without any meaningful treatments."

Gates said he was investing $50 million in the London-based Dementia Discovery Fund, a private-public venture that supports innovative research into dementia.

The multi-billionaire philanthropist said finding for Alzheimer's, which affects nearly 50 million people worldwide, was particularly urgent since improved medical care meant people were living longer.

He noted that his own father would soon celebrate his 92nd birthday—"a milestone that was practically unimaginable when he was born."

Gates said there is a nearly 50 percent chance of developing Alzheimer's for people who live into their mid-80s.

"If you get the in your 60s or 70s, you might require expensive care for decades," he said.

"Absent a major breakthrough, expenditures will continue to squeeze healthcare budgets in the years and decades to come," Gates said.

Gates acknowledged that making progress against Alzheimer's would be a long-term project.

"The first Alzheimer's treatments might not come to fruition for another decade or more, and they will be very expensive at first," he said.

"Once that day comes, our foundation might look at how we can expand access in ," he said.

But Gates said he was optimistic.

"We've seen scientific innovation turn once-guaranteed killers like HIV into chronic illnesses that can be held in check with medication," he said. "I believe we can do the same (or better) with Alzheimer's."

The Bill & Melinda Gates Foundation has concentrated mainly on fighting communicable diseases such as malaria and polio in poor countries.

Explore further: Bill Gates hopeful of AIDS vaccine in 10 years

Related Stories

Bill Gates hopeful of AIDS vaccine in 10 years

June 26, 2015
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

Recommended for you

Meditation and music may alter blood markers of cellular aging and Alzheimer's disease

November 13, 2018
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer's ...

Alzheimer's and cardiovascular disease share common genetics in some patients

November 9, 2018
Genetics may predispose some people to both Alzheimer's disease and high levels of blood lipids such as cholesterol, a common feature of cardiovascular disease, according to a new study by an international team of researchers ...

Artificial intelligence predicts Alzheimer's years before diagnosis

November 6, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer's disease, according to a study published in the journal Radiology.

Diabetes medications may reduce Alzheimer's disease severity

November 1, 2018
People with Alzheimer's disease who were treated with diabetes drugs showed considerably fewer markers of the disease—including abnormal microvasculature and disregulated gene expressions—in their brains compared to Alzheimer's ...

Massive study confirms that loneliness increases risk of dementia

October 29, 2018
A new Florida State University College of Medicine study involving data from 12,000 participants collected over 10 years confirms the heavy toll that loneliness can take on your health: It increases your risk of dementia ...

Bioactive compound from the Rhodiola plant improves memory

October 25, 2018
In an ageing society, more people are suffering from memory disorders. The progressive loss of memory severely impairs the quality of life of those affected. So far, no drugs are known to prevent age-related cognitive decline.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.